Association between chronic obstructive pulmonary disease and lung cancer: the missing link
1Department of Respiratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China. wangzengli@tom.com
Chinese Medical Journal
|January 5, 2013
Summary
Chronic obstructive pulmonary disease (COPD) significantly increases lung cancer risk in smokers. Understanding shared inflammatory pathways may lead to new diagnostics and treatments for these related lung diseases.
Area of Science:
- Pulmonology
- Oncology
- Pathogenesis
Background:
- Chronic obstructive pulmonary disease (COPD) and lung cancer are significant global health issues.
- Tobacco smoking is a primary risk factor for both conditions, with COPD increasing lung cancer risk up to 4.5-fold in smokers.
- Chronic airway inflammation is a key pathological process common to both COPD and lung cancer.
Purpose of the Study:
- To review current knowledge on the specific processes driving chronic airway inflammation in COPD and lung cancer.
- To explore the overlap and shared pathogenic mechanisms between COPD and lung cancer.
Main Methods:
- Literature search of PubMed database (1997-2012) using keywords 'COPD' and 'lung cancer'.
- Review of published articles on COPD prevalence, lung cancer development in COPD patients, and shared mechanisms.
Main Results:
- COPD is a major risk factor for lung cancer, present in 50%-90% of lung cancer patients.
- Chronic airway inflammation is central to the pathogenesis of both diseases.
- COPD diagnosis is frequently observed in lung cancer patients (50%-70%).
Conclusions:
- COPD and lung cancer share common risk factors (e.g., smoking) and pathogenic pathways.
- Targeting shared mechanisms offers potential for novel diagnostic and therapeutic strategies for these interconnected lung diseases.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: